mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.007 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.007 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.008 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.008 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.009 |
mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.009 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
0.01 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.01 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |